Volume 20, Number 10—October 2014
Research
Effects of Mefloquine Use on Plasmodium vivax Multidrug Resistance
Table 4
Variation in number of copies of Plasmodium vivax mdr-1 gene among isolates from persons from France who reported having traveled during the previous month to malaria-endemic continents, 1997–2010
Variable | South America | Asia | Africa | Total | p value |
---|---|---|---|---|---|
No. isolates | 41 | 60 | 14 | 115 | |
Isolates with >1 Pvmdr-1 copy | |||||
No. (%; 95% CI) | 14 (34; 18–57) | 23 (38; 24–57) | 8 (57; 24–100) | 45 (39; 30–49) | 0.30* |
Range | 1–2 | 1–3 | 1–2 | 1–3 | |
Copies, no. (%) | 0.49* | ||||
1 | 26 (63) | 37 (62) | 6 (43) | 70 (61) | |
2 | 14 (34) | 22 (37) | 8 (57) | 44 (38) | |
3 | 0 | 1 (2) | 0 | 1 (1) | |
Mean (95% CI) | 1.20 (1.05–1.35) | 1.40 (1.27–1.53) | 1.35 (1.10–1.59) | 1.32 (1.22–1.41) | 0.12† |
*χ2 test.
†1-Way analysis of variance.
Page created: September 12, 2014
Page updated: September 12, 2014
Page reviewed: September 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.